DPIIT recognised startup Government of India
Startup India
Mediframe India Private Limited
Mediframe India Private Limited - chemicals in Jaipur, Rajasthan, India. Directors, charges & compliance details.
Revenue · FY 2025
₹91.73 Lakh
▼ 10% YoY
Net profit · FY 2025
₹3.36 Lakh
Net margin 3.7%
EBITDA · FY 2025
₹4.87 Lakh
EBITDA margin 5.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹10 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Employees · EPFO
10
Provident fund records
About Mediframe India Private Limited
Data last updated:
Mediframe India Private Limited is a private limited company based in Jaipur, Rajasthan, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 09 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24290RJ2020PTC072040.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Amresh Khare and Shweta Sinha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. E – 5/37 2nd Flor Sector – 5 Chitrakoot Vaishali Nagar Jaipur, Rajasthan, India – 302021.
As per the financials filed for FY 2025, the company reported a revenue of ₹91.73 Lakh, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹3.36 Lakh (net margin 3.7%) and EBITDA of ₹4.87 Lakh (EBITDA margin 5.3%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years.
The company has about 10 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
Mediframe India Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0054855).
Company details
CIN U24290RJ2020PTC072040
Registration Number 072040
Incorporation Date 09 November 2020
ROC Jaipur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-RJ-17-0054855
Key People
Amresh Khare Director Shweta Sinha Director Recognitions & Rankings of Mediframe India
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-RJ-17-0054855
Contact details
Mediframe India Private Limited's registered office is in Jaipur, Rajasthan.
- Registered AddressFlat No. E – 5/37 2nd Flor Sector – 5 Chitrakoot Vaishali Nagar Jaipur, Rajasthan, India – 302021
- IndustryChemicals, Manufacturing, Other Chemical Product
Comprehensive company report
Mediframe India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Mediframe India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Mediframe India Private Limited, buy the company report.
Financials of Mediframe India Private Limited
FY 2025 filings availableMediframe India Private Limited reported revenue of ₹91.73 Lakh (down 10% YoY) for FY 2025.
Revenue · FY 2025
₹91.73 Lakh ▼ 10%
Net profit · FY 2025
₹3.36 Lakh margin 3.7%
EBITDA · FY 2025
₹4.87 Lakh margin 5.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 10%
3 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▲ 41%
3 years · compounded
▲ 33%
Revenue fell 10% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA rose 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.87 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.36 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.3% | ||||
| Net Profit Margin | 3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mediframe India Private Limited, buy the company report.
Board of directors of Mediframe India Private Limited
Mediframe India has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amresh Khare | Director | 09 Nov 2020 | 5 Years 11 Months | Current |
| Shweta Sinha | Director | 09 Nov 2020 | 5 Years 11 Months | Current |
Peer comparison
Mediframe India Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vampi Buildcon Private Limited | ₹91.76 Lakh (FY 2023) | 60.0% | Kolkata, West Bengal, India | |||
| Safeway Tradecom Private Limited | ₹91.76 Lakh (FY 2025) | -30.0% | Kolkata, West Bengal, India | |||
| Duta Formulations Private Limited | ₹91.76 Lakh (FY 2023) | 38.0% | Bangalore, Karnataka, India | |||
| Shyamvijay Infraestate Private Limited | ₹91.73 Lakh (FY 2025) | -2.0% | Ahmedabad, Gujarat, India | |||
| Hdlife Pharma and Labs Private Limited | ₹91.73 Lakh (FY 2024) | 37.0% | Guwahati, Assam, India | |||
| Mediframe India Private Limitedthis company | ₹91.73 Lakh (FY 2025) | ₹3.36 Lakh | 3.7% | -10.0% | Jaipur, Rajasthan, India | |
| SSK Labs Private Limited | ₹91.72 Lakh (FY 2024) | -38.0% | New Delhi, Delhi, India | |||
| Haze Shugart Enterprises Private Limited | ₹91.7 Lakh (FY 2022) | Thiruvananthapuram, Kerala, India | ||||
| Netcirque Technologies Private Limited | ₹91.68 Lakh (FY 2024) | -6.0% | New Delhi, Delhi, India | |||
| Aayumitra Wellness Private Limited | ₹91.68 Lakh (FY 2024) | 133.0% | Varanasi, Uttar Pradesh, India | |||
| Adeshwar Metals Private Limited | ₹91.67 Lakh (FY 2025) | -81.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Mediframe India Private Limited, buy the company report.
Charges & borrowings
Open charges
₹10 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Jul 2023 | 100755438 | Others | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Mediframe India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mediframe India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Mediframe India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Mediframe India Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Amresh Khare was appointed as Director on 09 Nov 2020.
AGM
Mediframe India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Mediframe India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Charges
A charge with Others amounted to Rs. 10.00 Lakh with Charge ID 100755438 was registered on 24 Jul 2023.
Appointed
Amresh Khare was appointed as Director.
Appointed
Shweta Sinha was appointed as Director.
Incorporation
09 Nov 2020
Mediframe India Private Limited was registered on 09 Nov 2020 with Roc Jaipur & aged 5 years 11 months as per MCA records.
Frequently asked questions
Mediframe India is an active private limited company based in Jaipur, Rajasthan, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 09 November 2020 (6+ years old) and is registered under CIN U24290RJ2020PTC072040.
Mediframe India has 2 current directors:
- Amresh Khare - Director
- Shweta Sinha - Director
The latest financial statements of Mediframe India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Mediframe India is U24290RJ2020PTC072040. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mediframe India was incorporated on 09 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Mediframe India by revenue are Vampi Buildcon Private Limited, Safeway Tradecom Private Limited, Duta Formulations Private Limited, Shyamvijay Infraestate Private Limited, Hdlife Pharma and Labs Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Amresh Khare was appointed as Director on 09 Nov 2020. Shweta Sinha was appointed as Director on 09 Nov 2020.
Yes, Mediframe India is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Mediframe India is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-17-0054855).
The registered office of Mediframe India is at Flat No. E – 537 2nd Flor Sector – 5 Chitrakoot Vaishali Nagar Jaipur, Rajasthan, India – 302021.
Mediframe India operates in the chemicals industry, in the manufacturing segment.